Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jul, 2019 | Pages:
90 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)
The global lung cancer screening software market size is estimated to reach USD 37.92 million by 2025 expanding at a CAGR of 19.5% from 2019 to 2025, according to a new report by Grand View Research, Inc. Growing incidence of lung cancer and rise in implementation of lung cancer screening programs across the globe are some of the significant factors driving the market growth. According to Globocan estimates, about 160,068 new cases of lung cancer were reported in South East Asian region in 2018. A number of clinical trials, studies, and demonstration projects are being conducted around the world to evaluate the effectiveness of lung cancer screening programs. For instance, in 2017, Cancer Care Ontario launched a screening pilot trial for people at high risk. Favorable government initiatives for successful implementation of such programs and increasing awareness about the disease screening are also likely to contribute to the market growth in the coming years. Lung cancer screening programs are widely adopted by hospitals and radiological centers in U.S. However, they are usually performed as a part of national or provisional screening program outside the country. In case of Latin America and Middle Eastern countries, limited availability of resources, restricted funding, low awareness levels, and lack of trained personnel are some of the factors that impede market growth. Further key findings from the study suggest: • In 2018, North America accounted for the highest revenue share owing to various lung cancer screening programs and favorable reimbursement scenario in the region • Asia Pacific is expected to be the fastest-growing regional market over the forecast period • This is attributed to the increasing cases of lung cancer and rise in the number of screening trials & studies for the disease • Nuance Communications, Inc.; Eon; Koninklijke Philips N.V.; Siemens Healthineers AG; PenRad Technologies, Inc.; MRS Systems, Inc.; and Magview are some of the key companies in the market
Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information procurement
1.3.1.1 Purchased database:
1.3.1.2 GVR's internal database
1.3.2 Primary research:
1.4 Research Scope and Assumptions
1.5 List to Data Sources
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Lung Cancer Screening Software Market Snapshot
Chapter 3 Lung Cancer Screening Software Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Reimbursement Framework
3.4 Regulatory Framework
3.5 Market Driver Analysis
3.6. Market Restraint Analysis
3.7 Industry Challenges
3.8 Lung Cancer Screening Software Market Analysis Tools
3.8.1 Industry analysis - Porter's
3.8.1.1 Bargaining power of suppliers - low
3.8.1.2 Bargaining power of the buyers - high
3.8.1.3 Threat of substitution - low
3.8.1.4 Threats of new entrants - moderately low
3.8.1.5 Competitive rivalry - high
3.8.2 PESTEL analysis
3.8.2.1 Political and legal landscape
3.8.2.2 Economic and social landscape
3.8.2.3 Technology landscape
3.9 Major Deals & Strategic Alliances Analysis
3.10. Market Entry Strategies
Chapter 4 Lung Cancer Screening Software Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
4.3 Vendor Landscape
4.3.1 List of key end-users
4.3.2 Company Market Position Analysis(Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
4.3.3 Company market share analysis
4.3.4 Market differentiators
Chapter 5 Lung Cancer Screening Software Market: Regional Estimates & Trend Analysis,
5.1 Lung Cancer Screening Software Market: Regional Movement Analysis
5.2 SWOT Analysis, by Factor (Political, Legal, Economic and Technological)
5.2.1 North America
5.2.2 Europe
5.2.3 Asia Pacific
5.2.4 Latin America
5.2.5 MEA
5.3 North America
5.3.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.3.2 U.S.
5.3.2.1 U.S. lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.3.3 Canada
5.3.3.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.4 Europe
5.4.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.4.2 U.K.
5.4.2.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.4.3 Germany
5.4.3.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.4.4 Italy
5.4.4.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.4.5 France
5.4.5.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.4.6 Spain
5.4.6.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.4.7 Russia
5.4.7.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.5 Asia Pacific
5.5.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.5.2 Japan
5.5.2.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.5.3 China
5.5.3.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.5.4 Australia
5.5.4.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.6 Latin America
5.6.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.6.2 Brazil
5.6.2.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.6.3 Mexico
5.6.3.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.7 MEA
5.7.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
5.7.2 South Africa
5.7.2.1 Market estimates and forecasts, 2014 - 2025 (USD Thousand)
Chapter 6 Competitive Landscape
6.1 Nuance Communications, Inc.
6.1.1 Company overview
6.1.2 Financial performance
6.1.3 Product benchmarking
6.1.4 Strategic initiatives
6.2 Eon
6.2.1 Company overview
6.2.2 Financial performance
6.2.3 Product benchmarking
6.2.4 Strategic initiatives
6.3 Koninklijke Philips N.V.
6.3.1 Company overview
6.3.2 Financial performance
6.3.3 Product benchmarking
6.3.4 Strategic initiatives
6.4 Siemens Healthineers AG
6.4.1 Company overview
6.4.2 Financial performance
6.4.3 Product benchmarking
6.4.4 Strategic initiatives
6.5 PenRad Technologies, Inc.
6.5.1 Company overview
6.5.2 Financial performance
6.5.3 Product benchmarking
6.5.4 Strategic initiatives
6.6 MRS Systems, Inc.
6.6.1 Company overview
6.6.2 Financial performance
6.6.3 Product benchmarking
6.6.4 Strategic initiatives
6.7 Magview
6.7.1 Company overview
6.7.2 Financial performance
6.7.3 Product benchmarking
6.7.4 Strategic initiatives
List of Tables Table 1. Global major lung cancer screening trials and demonstration projects Table 2. Major guidelines related to lung cancer screening
List of Figures Fig. 1 Market research process Fig. 2 Information procurement Fig. 3 Primary research pattern Fig. 4 Lung cancer screening software market summary Fig. 5 Regional market place: Key takeaways Fig. 6 Lung cancer screening software market: Regional movement analysis (USD Thousand) Fig. 7 Global lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand) Fig. 8 North America lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand) Fig. 9 U.S. lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand) Fig. 10 Number of lung cancer screening strategies in Canada Fig. 11 Canada lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand) Fig. 12. Europe lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand) Fig. 13 U.K. lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand) Fig. 14 Germany lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand) Fig. 15 Italy lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand) Fig. 16 France lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand) Fig. 17 Spain lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand) Fig. 18 Russia lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand) Fig. 19 Asia Pacific lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand) Fig. 20 Japan lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand) Fig. 21 China lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand) Fig. 22 Australia lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand) Fig. 23 Latin America lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand) Fig. 24 Brazil lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand) Fig. 25 Mexico lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand) Fig. 26 MEA lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand) Fig. 27 South Africa lung cancer screening software market estimates and forecasts, 2014 - 2025 (USD Thousand) Fig. 28 Market share of major lung cancer screening software players
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
